ArticleLangmuir : the ACS journal of surfaces and colloids2026
Hybrid Supercharged Antibodies: A Rational Approach to Boost Immunoassay Sensitivity via Controlled Nanoparticle Adsorption.
Article in Langmuir : the ACS journal of surfaces and colloids, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This study presents a novel approach to enhance the sensitivity of a lateral flow immunoassay by computationally designing supercharged antibodies that optimize both the adsorption amount and molecular orientation on nanoparticle surfaces. We engineered immunoglobulin G antibodies with positively charged Fc domains and negatively charged Fab domains to create charge-polarized molecules for controlled interaction with negatively charged cellulose nanoparticles (NanoAct). The supercharged antibodies retained physicochemical properties and antigen-binding affinities identical to those of the wild-type antibody. Quantitative analysis showed that positively supercharged Fc domains enhanced antibody adsorption, and the charge-polarized design (featuring a negatively charged Fab and a positively charged Fc; c-10/Fc-pos14) enhanced relative Fab accessibility on the nanoparticle surface. Interaction analyses between supercharged antibodies and NanoAct using isothermal titration calorimetry quantitatively revealed that the c-10/Fc-pos14 antibody adsorbed onto NanoAct in the tail-on orientation. Consequently, lateral flow immunoassay performance tests demonstrated an 8-fold improvement in the limit of detection from 25 to 3.13 ng/mL, without increasing nonspecific binding. The key design principle involves maintaining sufficient charge separation between the domains to ensure proper orientation control. This supercharging approach represents a promising strategy for boosting immunoassay sensitivity while preserving sufficiently low noise levels with potential applications in other antibody-based diagnostic platforms.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.